BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32896253)

  • 1. Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies.
    Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau JM; Miller FW; Selva-O'Callaghan A; Christopher-Stine L; Stenzel W; Mammen AL; Corse AM
    Clin Exp Rheumatol; 2021; 39(2):351-356. PubMed ID: 32896253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
    Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
    Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic inclusion body myositis: Diagnostic value of p62 immunostaining.
    Milisenda JC; García AM; Jou C; Pinal-Fernandez I; O'Callaghan AS; Grau JM
    Med Clin (Barc); 2019 Dec; 153(11):437-440. PubMed ID: 31253480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
    Zierer LK; Naegel S; Schneider I; Kendzierski T; Kleeberg K; Koelsch AK; Scholle L; Schaefer C; Naegel A; Zierz S; Otto M; Stoltenburg-Didinger G; Kraya T; Stoevesandt D; Mensch A
    J Neurol; 2024 Jun; 271(6):3186-3202. PubMed ID: 38438820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.
    Schmidt J; Barthel K; Wrede A; Salajegheh M; Bähr M; Dalakas MC
    Brain; 2008 May; 131(Pt 5):1228-40. PubMed ID: 18420712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
    Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
    Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies.
    Fischer N; Preuße C; Radke J; Pehl D; Allenbach Y; Schneider U; Feist E; von Casteleyn V; Hahn K; Ruck T; Meuth SG; Goebel HH; Graf R; Mammen A; Benveniste O; Stenzel W
    Brain Pathol; 2020 Mar; 30(2):261-271. PubMed ID: 31376301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
    Pinal-Fernandez I; Milisenda JC; Pak K; Muñoz-Braceras S; Casal-Dominguez M; Torres-Ruiz J; Dell'Orso S; Naz F; Gutierrez-Cruz G; Duque-Jaimez Y; Matas-Garcia A; Padrosa J; Garcia-Garcia FJ; Guitart-Mampel M; Garrabou G; Trallero-Araguás E; Walitt B; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Grau-Junyent JM; Selva-O'Callaghan A; Mammen AL
    Ann Rheum Dis; 2023 Aug; 82(8):1091-1097. PubMed ID: 37130727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy.
    Girolamo F; Lia A; Annese T; Giannini M; Amati A; D'Abbicco D; Tampoia M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Trojano M
    Muscle Nerve; 2019 Sep; 60(3):315-327. PubMed ID: 31172530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited.
    Knauss S; Preusse C; Allenbach Y; Leonard-Louis S; Touat M; Fischer N; Radbruch H; Mothes R; Matyash V; Böhmerle W; Endres M; Goebel HH; Benveniste O; Stenzel W
    Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e558. PubMed ID: 31044146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
    Pinal-Fernandez I; Quintana A; Milisenda JC; Casal-Dominguez M; Muñoz-Braceras S; Derfoul A; Torres-Ruiz J; Pak K; Dell'Orso S; Naz F; Gutierrez-Cruz G; Milone M; Shelly S; Duque-Jaimez Y; Tobias-Baraja E; Matas-Garcia A; Garrabou G; Padrosa J; Ros J; Trallero-Araguás E; Walitt B; Christopher-Stine L; Lloyd TE; Zhao C; Swift S; Rajan A; Grau-Junyent JM; Selva-O'Callaghan A; Liewluck T; Mammen AL
    Ann Rheum Dis; 2023 Jun; 82(6):829-836. PubMed ID: 36801811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
    Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The geoepidemiology of autoimmune muscle disease.
    Prieto S; Grau JM
    Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and diagnostic tools in idiopathic inflammatory myopathies.
    Tsamis KI; Boutsoras C; Kaltsonoudis E; Pelechas E; Nikas IP; Simos YV; Voulgari PV; Sarmas I
    Crit Rev Clin Lab Sci; 2022 Jun; 59(4):219-240. PubMed ID: 34767470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophils in hereditary and inflammatory myopathies.
    Schröder T; Fuchss J; Schneider I; Stoltenburg-Didinger G; Hanisch F
    Acta Myol; 2013 Dec; 32(3):148-53. PubMed ID: 24803842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
    Pinkus JL; Amato AA; Taylor JP; Greenberg SA
    Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
    Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.